TuisUTH • FRA
add
United Therapeutics Corporation
Vorige sluiting
€295,50
Dagwisseling
€294,00 - €294,00
Jaarwisseling
€192,30 - €302,00
Markkapitalisasie
14,52 mjd USD
Gemiddelde volume
9,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Mrt. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 677,70 m | 33,70% |
Bedryfskoste | 248,50 m | 46,00% |
Netto inkomste | 306,60 m | 27,27% |
Netto winsgrens | 45,24 | -4,80% |
Wins per aandeel | 6,17 | 26,95% |
EBITDA | 371,30 m | 24,72% |
Effektiewe belastingkoers | 23,08% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Mrt. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 2,71 mjd | -5,43% |
Totale bates | 6,50 mjd | 2,35% |
Totale aanspreeklikheid | 1,16 mjd | -5,37% |
Totale ekwiteit | 5,34 mjd | — |
Uitstaande aandele | 44,36 m | — |
Prys om te bespreek | 2,45 | — |
Opbrengs op bates | 13,04% | — |
Opbrengs op kapitaal | 14,08% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Mrt. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 306,60 m | 27,27% |
Kontant van bedrywe | 376,50 m | 0,45% |
Kontant van beleggings | 735,30 m | 432,56% |
Kontant van finansiering | -1,07 mjd | -2 297,53% |
Netto kontantverandering | 43,80 m | -78,35% |
Beskikbare kontantvloei | 293,68 m | -8,83% |
Meer oor
United Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR. It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Gestig
1996
Webwerf
Werknemers
1 168
